STOCK TITAN

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2023 Results: November 7, 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) announced plans to release its second quarter fiscal year 2023 financial results on November 7, 2022, at 6:00 am ET. An accompanying conference call will be held at 8:00 am ET the same day for investors and analysts to discuss the results. Participants can access the call via teleconference or live webcast on Haemonetics' investor relations website. A replay of the call will be available for one year starting at 11:00 am ET on November 7, 2022.

Positive
  • None.
Negative
  • None.

BOSTON, Oct. 6, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2023 financial results at 6:00 am ET on Monday, November 7, 2022. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on November 7, 2022.

The call can be accessed via teleconference at: Q2 2023 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link:https://edge.media-server.com/m6/p/qyrbnnof https://edge.media-server.com/mmc/p/jmqoyvd8 

A replay of the conference call and webcast will be available for one year beginning on November 7, 2022 at 11:00 am ET using the conference call webcast link provided in this press release.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contact:
Olga Guyette, Sr. Director, Investor Relations & Treasury
(781) 356-9763
olga.guyette@haemonetics.com

Media Contact:
Josh Gitelson, Director, Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-second-quarter-fiscal-year-2023-results-november-7-2022-301643084.html

SOURCE Haemonetics Corporation

FAQ

When does Haemonetics plan to announce Q2 FY 2023 results?

Haemonetics plans to announce Q2 FY 2023 results on November 7, 2022, at 6:00 am ET.

What time will the conference call for Haemonetics' Q2 earnings be held?

The conference call for Haemonetics' Q2 earnings will be held at 8:00 am ET on November 7, 2022.

How can I access the Haemonetics Q2 FY 2023 earnings conference call?

The Haemonetics Q2 FY 2023 earnings conference call can be accessed via teleconference or through a live webcast on their investor relations website.

Will a replay of Haemonetics' Q2 earnings call be available?

Yes, a replay of Haemonetics' Q2 earnings call will be available for one year starting at 11:00 am ET on November 7, 2022.

Haemonetics Corporation

NYSE:HAE

HAE Rankings

HAE Latest News

HAE Stock Data

4.49B
50.22M
0.89%
116%
10.28%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
BOSTON